Stromal cell-derived factor-1 (SDF-1) expression in very preterm human lungs: potential relevance for stem cell therapy for bronchopulmonary dysplasia

References

• Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr. 2011;23(2):167–172. doi:10.1097/MOP.0b013e3283423e6b.
   PubMed Web of Science ®Google Scholar
• Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol. 1998;29(7):710–717. doi:10.1016/S0046-8177(98)90280-5.
   PubMed Web of Science ®Google Scholar
• Stoll BJ, Hansen NI, Bell EF, et al. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA. 2015;314(10):1039–1051. doi:10.1001/jama.2015.10244.
   PubMed Web of Science ®Google Scholar
• Poindexter BB, Feng R, Schmidt B, et al. Comparisons and limitations of current definitions of bronchopulmonary dysplasia for the prematurity and respiratory outcomes program. Annals ATS. 2015;12(12):1822–1830. doi:10.1513/AnnalsATS.201504-218OC.
   Web of Science ®Google Scholar
• Costeloe KL, Hennessy EM, Haider S, Stacey F, Marlow N, Draper ES. Short term outcomes after extreme preterm birth in England: comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ. 2012;345(3):e7976–e7976. doi:10.1136/bmj.e7976.
   PubMed Web of Science ®Google Scholar
• Ancel PY, Goffinet F, Kuhn P, et al. Survival and morbidity of preterm children born at 22 through 34 weeks’ gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr. 2015;169(3):230–238. doi:10.1001/jamapediatrics.2014.3351.
   PubMed Web of Science ®Google Scholar
• Kinsella JP, Greenough A, Abman SH. Bronchopulmonary dysplasia. Lancet. 2006;367(9520):1421–1431. doi:10.1016/S0140-6736(06)68615-7.
   PubMed Web of Science ®Google Scholar
• Bancalari E, Jain D. Bronchopulmonary dysplasia: 50 Years after the original description. Neonatology. 2019;115(4):384–391. doi:10.1159/000497422.
   PubMed Web of Science ®Google Scholar
• Lee JW, Fang X, Gupta N, Serikov V, Matthay MA. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung. Proc Natl Acad Sci USA. 2009;106(38):16357–16362. doi:10.1073/pnas.0907996106.
   PubMed Web of Science ®Google Scholar
• Davis NE, Hamilton D, Fontaine MJ. Harnessing the immunomodulatory and tissue repair properties of mesenchymal stem cells to restore beta cell function. Curr Diab Rep. 2012;12(5):612–622. doi:10.1007/s11892-012-0305-4.
   PubMed Web of Science ®Google Scholar
• Antunes MA, Laffey Jg Pelosi P, Rocco PR. Mesenchymal stem cell trials for pulmonary diseases. J Cell Biochem. 2014;115(6):1023-1032.
   Web of Science ®Google Scholar
• Kuchroo P, Dave V, Vijayan A, Viswanathan C, Ghosh D. Paracrine factors secreted by umbilical cord-derived mesenchymal stem cells induce angiogenesis in vitro by a VEGF-independent pathway. Stem Cells Dev. 2015;24(4):437–450. doi:10.1089/scd.2014.0184.
   PubMed Web of Science ®Google Scholar
• Shen C, Lie P, Miao T, et al. Conditioned medium from umbilical cord mesenchymal stem cells induces migration and angiogenesis. Mol Med Rep. 2015;12(1):20–30. doi:10.3892/mmr.2015.3409.
   PubMed Web of Science ®Google Scholar
• Dey R, Kemp K, Gray E, Rice C, Scolding N, Wilkins A. Human mesenchymal stem cells increase anti-oxidant defences in cells derived from patients with Friedreich’s ataxia. Cerebellum. 2012;11(4):861–871. doi:10.1007/s12311-012-0406-2.
   PubMed Web of Science ®Google Scholar
• Liu H, McTaggart SJ, Johnson DW, Gobe GC. Original article anti-oxidant pathways are stimulated by mesenchymal stromal cells in renal repair after ischemic injury. Cytotherapy. 2012;14(2):162–172. doi:10.3109/14653249.2011.613927.
   PubMed Web of Science ®Google Scholar
• Ee MT, Thebaud B. The therapeutic potential of stem cells for bronchopulmonary dysplasia: “it’s about time” or “not so fast? Curr Pediatr Rev. 2018;14(4):227–238. doi:10.2174/1573396314666180911100503.
   PubMed Web of Science ®Google Scholar
• Sung DK, Chang YS, Ahn SY, et al. Optimal route for human umbilical cord blood-derived mesenchymal stem cell transplantation to protect against neonatal hyperoxic lung injury: gene expression profiles and histopathology. PLoS One. 2015;10(8):e0135574. doi:10.1371/journal.pone.0135574.
   PubMed Web of Science ®Google Scholar
• Chang YS, Ahn Sy Yoo Hs, et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr. 2014;164(5):966-972.
   Web of Science ®Google Scholar
• Ahn SY, Chang YS, Kim JH, Sung SI, Park WS. Two-year follow-up outcomes of premature infants enrolled in the phase I trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia. J Pediatr. 2017;185:49–54. doi:10.1016/j.jpeds.2017.02.061.
   PubMed Web of Science ®Google Scholar
• Powell SB, Silvestri JM. Safety of intratracheal administration of human umbilical cord blood derived mesenchymal stromal cells in extremely low birth weight preterm infants. J Pediatr. 2019;210:209–213. doi:10.1016/j.jpeds.2019.02.029.
   PubMed Web of Science ®Google Scholar
• Fung ME, Thebaud B. Stem cell-based therapy for neonatal lung disease: it is in the juice. Pediatr Res. 2014;75(1):2–7. doi:10.1038/pr.2013.176.
   PubMed Web of Science ®Google Scholar
• Collins JJ, Thebaud B. Lung mesenchymal stromal cells in development and disease: to serve and protect?. Antioxid Redox Signal. 2014;21(13):1849–1862. doi:10.1089/ars.2013.5781.
   PubMed Web of Science ®Google Scholar
• Sdrimas K, Kourembanas S. MSC microvesicles for the treatment of lung disease: a new paradigm for cell-free therapy. Antioxid Redox Signal. 2014;21(13):1905–1915. doi:10.1089/ars.2013.5784.
   PubMed Web of Science ®Google Scholar
• Marquez-Curtis LA, Janowska-Wieczorek A. Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis. BioMed Res Int. 2013;2013:1–15. doi:10.1155/2013/561098.
   Web of Science ®Google Scholar
• Cencioni C, Capogrossi MC, Napolitano M. The SDF-1/CXCR4 axis in stem cell preconditioning. Cardiovasc Res. 2012;94(3):400–407. doi:10.1093/cvr/cvs132.
   PubMed Web of Science ®Google Scholar
• Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996;184(3):1101–1109. doi:10.1084/jem.184.3.1101.
   PubMed Web of Science ®Google Scholar
• Kim CH, Broxmeyer HE. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood. 1998;91(1):100–110. doi:10.1182/blood.V91.1.100.
   PubMed Web of Science ®Google Scholar
• Ji JF, He BP, Dheen ST, Tay SS. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells. 2004;22(3):415–427. doi:10.1634/stemcells.22-3-415.
   PubMed Web of Science ®Google Scholar
• Wang Y, Deng Y, Zhou GQ. SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res. 2008;1195:104–112. doi:10.1016/j.brainres.2007.11.068.
   PubMed Web of Science ®Google Scholar
• Kitaori T, Ito H, Schwarz EM, et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum. 2009;60(3):813–823. doi:10.1002/art.24330.
   PubMed Web of Science ®Google Scholar
• Hu C, Yong X, Li C, et al. CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair. J Surg Res. 2013;183(1):427–434. doi:10.1016/j.jss.2013.01.019.
   PubMed Web of Science ®Google Scholar
• Liu H, Liu S, Li Y, et al. The role of SDF-1-CXCR4/CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia/reperfusion injury. PLoS One. 2012;7(4):e34608. doi:10.1371/journal.pone.0034608.
   PubMed Web of Science ®Google Scholar
• Abbott JD, Huang Y, Liu D, Hickey R, Krause DS, Giordano FJ. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation. 2004;110(21):3300–3305. doi:10.1161/01.CIR.0000147780.30124.CF.
   PubMed Web of Science ®Google Scholar
• Ghadge SK, Muhlstedt S, Ozcelik C, Bader M. SDF-1alpha as a therapeutic stem cell homing factor in myocardial infarction. Pharmacol Ther. 2011;129(1):97–108. doi:10.1016/j.pharmthera.2010.09.011.
   PubMed Web of Science ®Google Scholar
• Penn MS, Pastore J, Miller T, Aras R. SDF-1 in myocardial repair. Gene Ther. 2012;19(6):583–587. doi:10.1038/gt.2012.32.
   PubMed Web of Science ®Google Scholar
• Yu J, Li M, Qu Z, Yan D, Li D, Ruan Q. SDF-1/CXCR4-mediated migration of transplanted bone marrow stromal cells toward areas of heart myocardial infarction through activation of PI3K/Akt. J Cardiovasc Pharmacol. 2010;55(5):496–505. doi:10.1097/FJC.0b013e3181d7a384.
   PubMed Web of Science ®Google Scholar
• Kucia M, Ratajczak J, Reca R, Janowska-Wieczorek A, Ratajczak MZ. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis. 2004;32(1):52–57. doi:10.1016/j.bcmd.2003.09.025.
   PubMed Web of Science ®Google Scholar
• Wilson GC, Freeman CM, Kuethe JW, et al. CXC chemokine receptor-4 signaling limits hepatocyte proliferation after hepatic ischemia-reperfusion in mice. Am J Physiol Gastrointest Liver Physiol. 2015;308(8):G702–709. doi:10.1152/ajpgi.00257.2014.
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhao RC. The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev and Rep. 2012;8(1):243–250. doi:10.1007/s12015-011-9293-z.
   PubMed Web of Science ®Google Scholar
• Liu X, Duan B, Cheng Z, et al. SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion. Protein Cell. 2011;2(10):845–854. doi:10.1007/s13238-011-1097-z.
   PubMed Web of Science ®Google Scholar
• Janssens R, Struyf S, Proost P. Pathological roles of the homeostatic chemokine CXCL12. Cytokine Growth Factor Rev. 2018;44:51–68. doi:10.1016/j.cytogfr.2018.10.004.
   PubMed Web of Science ®Google Scholar
• Dorman SC, Babirad I, Post J, et al. Progenitor egress from the bone marrow after allergen challenge: role of stromal cell-derived factor 1alpha and eotaxin. J Allergy Clin Immunol. 2005;115(3):501–507. doi:10.1016/j.jaci.2004.11.017.
   PubMed Web of Science ®Google Scholar
• Doyle TM, Ellis R, Park HJ, Inman MD, Sehmi R. Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma. Eur Respir J. 2011;38(3):679–687. doi:10.1183/09031936.00133210.
   PubMed Web of Science ®Google Scholar
• Suga A, Ueda K, Takemoto Y, et al. Significant role of bone marrow-derived cells in compensatory regenerative lung growth. J Surg Res. 2013;183(1):84–90. doi:10.1016/j.jss.2012.12.013.
   PubMed Web of Science ®Google Scholar
• Petty JM, Sueblinvong V, Lenox CC, et al. Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol. 2007;178(12):8148–8157. doi:10.4049/jimmunol.178.12.8148.
   PubMed Web of Science ®Google Scholar
• Deng C, Wang J, Zou Y, et al. Characterization of fibroblasts recruited from bone marrow-derived precursor in neonatal bronchopulmonary dysplasia mice. J Appl Physiol. 2011;111(1):285–294. (1985). doi:10.1152/japplphysiol.00201.2010.
   PubMed Web of Science ®Google Scholar
• Drummond S, Ramachandran S, Torres E, et al. CXCR4 blockade attenuates hyperoxia-induced lung injury in neonatal rats. Neonatology. 2015;107(4):304–311. doi:10.1159/000371835.
   PubMed Web of Science ®Google Scholar
• Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2007;292(5):L1073–1084. doi:10.1152/ajplung.00347.2006.
   PubMed Web of Science ®Google Scholar
• De Paepe ME, Friedman RM, Gundogan F, Pinar H. Postmortem lung weight/body weight standards for term and preterm infants. Pediatr Pulmonol. 2005;40(5):445–448. doi:10.1002/ppul.20218.
   PubMed Web of Science ®Google Scholar
• De Paepe ME, Mao Q, Ghanta S, Hovanesian V, Padbury JF. Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells. Am J Pathol. 2011;178(3):1329–1339. doi:10.1016/j.ajpath.2010.11.062.
   PubMed Web of Science ®Google Scholar
• Jin W, Liang X, Brooks A, et al. Modelling of the SDF-1/CXCR4 regulated in vivo homing of therapeutic mesenchymal stem/stromal cells in mice. PeerJ. 2018;6:e6072. doi:10.7717/peerj.6072.
   PubMed Web of Science ®Google Scholar
• Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood. 2005;105(10):3793–3801. doi:10.1182/blood-2004-11-4349.
   PubMed Web of Science ®Google Scholar
• Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006;24(4):1030–1041. doi:10.1634/stemcells.2005-0319.
   PubMed Web of Science ®Google Scholar
• Naderi-Meshkin H, Bahrami AR, Bidkhori HR, Mirahmadi M, Ahmadiankia N. Strategies to improve homing of mesenchymal stem cells for greater efficacy in stem cell therapy. Cell Biol Int. 2015;39(1):23–34. doi:10.1002/cbin.10378.
   PubMed Web of Science ®Google Scholar
• Murphy JW, Cho Y, Sachpatzidis A, Fan C, Hodsdon ME, Lolis E. Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin. J Biol Chem. 2007;282(13):10018–10027. doi:10.1074/jbc.M608796200.
   PubMed Web of Science ®Google Scholar
• Ma J, Ge J, Zhang S, et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol. 2005;100(3):217–223. doi:10.1007/s00395-005-0521-z.
   PubMed Web of Science ®Google Scholar
• Kato T, Khanh VC, Sato K, et al. SDF-1 improves wound healing ability of glucocorticoid-treated adipose tissue-derived mesenchymal stem cells. Biochem Biophys Res Commun. 2017;493(2):1010–1017. doi:10.1016/j.bbrc.2017.09.100.
   PubMed Web of Science ®Google Scholar
• Walker ND, Mourad Y, Liu K, et al. Steroid-mediated decrease in blood mesenchymal stem cells in liver transplant could impact long-term recovery. Stem Cell Rev and Rep. 2017;13(5):644–658. doi:10.1007/s12015-017-9751-3.
   PubMed Web of Science ®Google Scholar